Company news

Scienture Holdings, Inc. (NASDAQ:SCNX) news

Scienture Holdings, Inc. news releases on 6ix. Latest, Sep 24, 2024: TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol…

Scienture Holdings, Inc. (NASDAQ:SCNX) news

Press releases — page 2

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.

TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

TRxADE Health, Inc. Announces Special Cash Dividend

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Trxade health, Inc files its 3Q 10Q

TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.

TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.

Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales

Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.

Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand

Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.

TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing

Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team

TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern Time

TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.

TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.

Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution

Superlatus, Inc. Announces New Appointments to the Management Team

TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)

Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform

EAT WELL GROUP TO SELL SAPIENTIA FOR USD $10 MILLION IN NASDAQ MERGER WITH MEDS & SUPERLATUS FOODS

TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split

TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results

TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 15th at 6:00 p.m. Eastern Time

TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 8th at 5:00 p.m. Eastern Time

TRxADE HEALTH Reports 16% Revenue Growth and Year End 2022 Financial Results

TRxADE HEALTH, INC. to Report Q4 and Year-End 2022 Financial Results on Monday, March 27th at 5:30 p.m. Eastern Time

Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model

TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results

Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups

TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m. Eastern Time

TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering

TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors

Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal

TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program

TRxADE HEALTH Announces Termination of Public Offering of Common Stock

TRxADE HEALTH Announces Proposed Public Offering of Common Stock

TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr. Jeff Newell to its Advisory Board

TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results

Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC

TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m. Eastern Time

Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services

TRxADE HEALTH Reports First Quarter Revenue Growth of 6% and Q1 2022 Financial Results

TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m. Eastern Time

TRxADE HEALTH Reports Year End 2021 Financial Results

TRxADE HEALTH, INC. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT